The contract research organization will launch an expanded ISO 18562 gas pathway testing program and ISO 10993-18 particulate ...
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--TÜV SÜD announces its plans to expand its Medical & Health Services (MHS) facilities in New Brighton, Minnesota, during a groundbreaking ceremony. This 20,000 ...
Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launcheda GMPPFAS ...
NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
Good Laboratory Practice certification expands company's ability to support medical device manufacturers in meeting the complex demands of international regulatory frameworks "Our customers are ...
On April 29, 2024, the US Food and Drug Administration (FDA) issued the long-awaited final rule around the regulation of laboratory developed tests (LDTs), which are in vitro diagnostic products (IVDs ...
Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...
Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...
Eurofins Medical Device Services is setting new standards with the industry's first GMP PFAS testing and advanced PFAS Risk Assessments for medical devices. LANCASTER, Pa., December 02, ...